Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Automated texting system for at-home monitoring of COVID-19 patients shown to save lives

Written by | 17 Nov 2021

Patients enrolled in COVID Watch were 68 percent less likely to die from COVID-19. A retrospective cohort analysis found that an algorithm-based automated text messaging system saved a… read more.

Researchers discover a way to increase the effectiveness of antibiotics

Written by | 16 Nov 2021

A multi-disciplinary project driven by EMBL Australia researchers at Monash University and Harvard University has found a way to make antibiotics more effective against antibiotic-resistant bacteria — also… read more.

COVID-19: The older you are, the more antibodies you have

Written by | 14 Nov 2021

Does natural infection or vaccination prompt the body to generate more protective antibodies? It’s a question that researchers have been working on since the introduction of the first… read more.

Convenience the key to increased childhood vaccination

Written by | 12 Nov 2021

Ensuring high levels of vaccination in children has helped to eradicate smallpox, eliminate polio in all but two countries of the world, and drive down rates of measles…. read more.

FDA Advisory Committee unanimously votes in support of emergency use for a booster dose of Moderna’s COVID-19 Vaccine in the U.S

Written by | 27 Oct 2021

Moderna, Inc. confirmed that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended that the FDA grant an Emergency Use Authorization (EUA) for a booster dose… read more.

FDA approves expanded indication of Biktarvy for treatment of HIV-1 in pediatric populations – Gilead Sciences

Written by | 26 Oct 2021

Gilead Sciences, Inc. announced the FDA approved a new low-dose tablet dosage form of Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets) for pediatric patients weighing… read more.

FDA accepts REGEN-COV for priority review for treatment and prophylaxis of COVID-19 – Regeneron Pharma

Written by | 17 Oct 2021

Regeneron Pharmaceuticals, Inc. has announced that the FDA has accepted for priority review a Biologics License Application (BLA) for REGEN-COV (casirivimab and imdevimab) to treat COVID-19 in non-hospitalized… read more.

CHMP recommends Artesunate Amivas for the initial treatment of severe malaria – Amivas

Written by | 13 Oct 2021

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Artesunate Amivas, intended for… read more.

Ebola Vaccine Regimen demonstrated robust and durable immune response in adults and children in data published in The Lancet Infectious Diseases – Johnson & Johnson

Written by | 7 Oct 2021

Data from two papers published in The Lancet Infectious Diseases demonstrated that the Johnson & Johnson (the Company) Ebola vaccine regimen, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo), generated robust… read more.

Johnson & Johnson announces real-world evidence and phase III data confirming strong and long-lasting protection of single-shot COVID-19 vaccine in the U.S.

Written by | 3 Oct 2021

Johnson & Johnson announced new data reinforcing the strong and long-lasting protection of its COVID-19 vaccine . New data also showed that protection against COVID-19 increases when a… read more.

New findings on ambient UVB radiation, vitamin D, and protection against severe COVID-19

Written by | 1 Oct 2021

New research from Trinity College Dublin and University of Edinburgh has examined the association between vitamin D and COVID-19, and found that ambient ultraviolet B (UVB) radiation (which… read more.

Analyses published in NEJM of a third booster shot of the Comirnaty messenger RNA vaccine from Pfizer

Written by | 19 Sep 2021

Publication of two separate analyses in The New England Journal of Medicine comes before a meeting of FDA advisers to discuss Pfizer’s application for authorization of a third… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.